[Code of Federal Regulations] [Title 21, Volume 6] [Revised as of January 1, 2003] From the U.S. Government Printing Office via GPO Access [CITE: 21CFR529.1940] [Page 329-330] TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) PART 529--CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS--Table of Contents Sec. 529.1940 Progesterone intravaginal inserts. (a) Specifications. Each insert contains 1.38 grams of progesterone in molded silicone over a nylon spine. (b) Sponsor. See No. 000009 in Sec. 510.600(c) of this chapter. (c) Related tolerances. See Sec. 556.540(a) of this chapter. (d) Special considerations. (1) Wear latex gloves when handling inserts. Store removed inserts in a plastic bag or other sealable container until they can be disposed in accordance with applicable local, State, and Federal regulations. (2) This product is approved with the concurrent use of dinoprost solution on day 6 of the 7-day administration period. See Sec. 522.690(c) of this chapter. (e) Conditions of use--(1) Amount. Administer one intravaginal insert per animal for 7 days. Administer 25 milligrams (mg) dinoprost (5 milliliters (mL) of 5 mg/mL solution as in Sec. 522.690(a) of this chapter) 1 day prior to insert removal. (2) Indications for use. For synchronization of estrus in suckled beef cows and replacement beef and dairy heifers, for advancement of first postpartum estrus in suckled beef cows, and for advancement of first pubertal estrus in replacement beef heifers. (3) Limitations. Do not use in animals with abnormal, immature, or infected genital tracts; or in beef cows that are fewer than 20 days postpartum; or in beef or dairy heifers of insufficient size or age for breeding; or in lactating dairy cows. Do not use an insert more than once. To prevent the potential transmission of venereal and bloodborne diseases, the inserts should be disposed after a single use. Administration of vaginal inserts for periods greater than 7 days may result in reduced fertility. Dinoprost solution as [[Page 330]] provided by No. 000009 in Sec. 510.600(c) of this chapter. [67 FR 41824, June 20, 2002, as amended at 67 FR 51080, Aug. 7, 2002]